Management of haemophilia B inhibitor patients with anaphylactic reactions to FIX concentrates

Haemophilia

Volumn 9, Issue 3, 2003, Pages 269-271

  Shibata, M ^a   Shima, Midori ^a   Misu, H ^b   Okimoto, Y ^c   Giddings, J C ^d   Yoshioka, A ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b KOBE CHILDREN S HOSPITAL   (Japan)

^c CHIBA CHILDREN'S HOSPITAL   (Japan)

^d CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Anaphylaxis; Factor IX; Haemophilia B; Inhibitor; Management

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; BLOOD CLOTTING FACTOR 9 CONCENTRATE; HYDROCORTISONE; IMMUNOGLOBULIN E; PROTHROMBIN COMPLEX; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANAPHYLAXIS; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INFUSION; DRUG WITHDRAWAL; HEMOPHILIA B; HUMAN; HUMAN TISSUE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; SKIN TEST; TREATMENT OUTCOME; URTICARIA;

EID: 0038779281     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.2003.00772.x     Document Type: Article

References (5)

1. Warrier I. Management of haemophilia B patients with inhibitors and anaphylaxis. Haemophilia 1998; 4: 574-6.
2. Hender U. FVIIa in the treatment of haemophilia. Blood Coagul Fibrinolysis 1990; 1: 307-17.
3. Barnes C, Rudzki Z, Ekert H. Induction of immune tolerance and suppression of anaphylaxis in a child with haemophilia B by simple plasmapheresis and antigen exposure. Haemophilia 2000; 6: 693-5.
4. Dioun AF, Ewenstein BM, Geha RS, Schneider LC. IgE-mediated allergy and desensitization to factor IX in hemophilia B. J Allergy Clin Immunol 1998; 102: 113-7.
5. Ewenstein BM, Takemoto C, Warrier I et al. Nephrotic syndrome as a complication of immune tolerance in hemophilia B. Blood 1997; 89: 1115-6.